Targovax ASA: First Quarter 2019 Results
OSLO, Norway, May 9, 2019 /PRNewswire/ — Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its first quarter 2019 results. A meeting for investors, analysts and press will take place in Oslo …
View more at https://www.prnewswire.com:443/news-releases/targovax-asa-first-quarter-2019-results-300846984.html
Comments Off on Targovax ASA: First Quarter 2019 Results